100
Participants
Start Date
August 31, 2007
XL019
gelatin capsules supplied in 5-mg, 25-mg, and 100-mg strengths
Mt. Sinai School of Medicine, New York
H. Lee Moffitt Cancer Center & Research Institute, Tampa
MD Anderson Cancer Center, Houston
UCSF - Division of Hematology/Oncology, San Francisco
Dana Farber Cancer Institute, Boston
Lead Sponsor
Exelixis
INDUSTRY